Journal Article

Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens

Charles L. Crespi, Bruce W-Penman, Dorothy T. Steimel, Theresa Smith, Chung S. Yang and Thomas R. Sutter

in Mutagenesis

Published on behalf of United Kingdom Environmental Mutagen Society

Volume 12, issue 2, pages 83-89
Published in print March 1997 | ISSN: 0267-8357
Published online March 1997 | e-ISSN: 1464-3804 | DOI: http://dx.doi.org/10.1093/mutage/12.2.83
Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens

More Like This

Show all results sharing these subjects:

  • Clinical Cytogenetics and Molecular Genetics
  • Genetics and Genomics

GO

Show Summary Details

Preview

An AHH-1 TK+/− cell derivative was developed that stably expresses human cytochrome P4501B1 (CYP1B1) cDNA in an extrachromosomal vector which confers resistance to 1-histidinol and co-expresses NADPH cytochrome P450 oxidoreductase (OR). The CYP1B1-expressing cell line was designated h1B1/OR. Microsomes prepared from CYP1B1 cDNA expressing cells exhibit elevated levels of 7-ethoxyresorufin deethylase (EROD), 7-ethoxy-4-trifluoromethylcoumarin deethylase (EFCD), benzo(a)pyrene hydroxylase (BPH), bufuralol 1'-hydroxylase, testosterone hydroxylase activities and spectrally quantifiable cytochrome P450. CYP1B1-containing microsomes did not contain detectable coumarin 7-hydroxylase, p-nitrophenol hydroxylase, lauric acid hydroxylase, (S)-mephenytoin 4'-hydroxylase or diclofenac 4'-hydroxylase activities. Kinetic parameters for selected substrates were compared among CYP1B1 and the two additional members of the CYP1 family, CYP1A1 and CYP1A2. For BPH and EFCD, the rank order of rates of substrate metabolism were CYP1A1>CYP1B1> CYP1A2. For EROD, the rank order of substrate metabolism was CYP1A1>CYP1A2>CYP1B1. For both EROD and EFCD the apparent Km values for CYP1B1 were more similar to CYP1A1 than to CYP1A2. In order to begin to characterize the promutagen activating ability of CYP1B1, the mutagenicity of selected chemicals was examined in h1B1/OR cells; there was increased sensitivity (CYP1B1-expressing relative to control cells) to the mutagenicity of benzo(apyrene, cyclopenta(c,d)pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and aflatoxin B, (AFB). CYP1B1, expressed in this system, appears to be particularly efficient at activating AFB.

Journal Article.  0 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics ; Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.